Skip to main content
. 2011 Jul 7;16(9):1280–1291. doi: 10.1634/theoncologist.2010-0349

Figure 4.

Figure 4.

Kaplan-Meier curves for OS of BCL2L12 (A) and BCL2 (B) mRNA-positive and mRNA-negative chronic lymphocytic leukemia patients. BCL2L12 mRNA expression has an unfavorable prognostic value for chronic lymphocytic leukemia, as BCL2L12-positive patients have significantly shorter OS time, in comparison with BCL2L12-negative patients. Abbreviation: OS, overall survival.